Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 20;32(4):32-40.

The Department of Defense Global Respiratory Pathogen Surveillance Program: its impact on public health, from the U.S. Armed Forces to global health

William E Gruner  1 , Laurie S DeMarcus  2 , Jeffrey W Thervil  2 , Bismark Kwaah  2 , Whitney N Jenkins  2 , Amy L Bogue  2 , Tamara R Hartless  2 , Anthony S Robbins  3 , James F Hanson  4 , Jimmaline J Hardy  1 , Deanna M Muehlman  1 , Anthony C Fries  4 , Elizabeth A Macias  4
Affiliations

The Department of Defense Global Respiratory Pathogen Surveillance Program: its impact on public health, from the U.S. Armed Forces to global health

William E Gruner et al. MSMR. .
No abstract available

Keywords: Armed Forces; Department of Defense; DoDGRPSP; Global Respiratory Pathogen Surveillance Program; United States; disease; global; military; outbreak; respiratory illness; surveillance.

Plain language summary

This guest editorial provides information on the U.S. Department of Defense Global Respiratory Pathogen Surveillance Program’s collaborations throughout the Department of Defense as well as other government agencies, its surveillance network, specimen testing capabilities and protocols, in-depth pathogen characterization, and impacts on public health.

PubMed Disclaimer

Conflict of interest statement

The work described in this manuscript was funded each year by Global Emerging Infections Surveillance (GEIS) Branch, Armed Forces Health Surveillance Division (AFHSD). The views expressed are those of the authors and do not reflect the official guidance nor position of the United States Government, Department of Defense, Defense Health Agency, or the Department of the Air Force.

Figures

FIGURE 1a.
FIGURE 1a.
Influenza Clades for Influenza Subtype A(H1N1)pdm09, Influenza Subtype A(H3N2), Influenza Subtype B / Victoria, and Influenza Subtype B / Yamagata, October 2014–August 2024 Influenza Subtype A(H1N1)pdm09
FIGURE 1b.
FIGURE 1b.
Influenza Clades for Influenza Subtype A(H1N1)pdm09, Influenza Subtype A(H3N2), Influenza Subtype B / Victoria, and Influenza Subtype B / Yamagata, October 2014–August 2024 Influenza Subtype A(H3N2)
FIGURE 1c.
FIGURE 1c.
Influenza Clades for Influenza Subtype A(H1N1)pdm09, Influenza Subtype A(H3N2), Influenza Subtype B / Victoria, and Influenza Subtype B / Yamagata, October 2014–August 2024 Influenza Subtype B / Victoria
FIGURE 1d.
FIGURE 1d.
Influenza Clades for Influenza Subtype A(H1N1)pdm09, Influenza Subtype A(H3N2), Influenza Subtype B / Victoria, and Influenza Subtype B / Yamagata, October 2014–August 2024 Influenza Subtype B / Yamagata
FIGURE 2a.
FIGURE 2a.
Vaccine Effectiveness, Influenza Subtype A(H1N1)pdm09, Influenza Subtype A(H3N2), and Influenza B, 2017–2024 Influenza Subtype A(H1N1)pdm09
FIGURE 2b.
FIGURE 2b.
Vaccine Effectiveness, Influenza Subtype A(H1N1)pdm09, Influenza Subtype A(H3N2), and Influenza B, 2017–2024 Influenza Subtype A(H3N2)
FIGURE 2c.
FIGURE 2c.
Vaccine Effectiveness, Influenza Subtype A(H1N1)pdm09, Influenza Subtype A(H3N2), and Influenza B, 2017–2024 Influenza B
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. MacIntosh V , Noe J , Zorich S , Macias E , DeMarcus L.. The Department of Defense Global, Laboratory-Based Influenza Surveillance Program: Technical Report on Program Methods for the 2012-2013 Influenza Season . Defense Technical Information Center; ; 2014. . Accessed Apr. 16, 2025 . https://apps.dtic.mil/sti/citations/ADA599690
    1. Vaccines and Related Biological Products Advisory Committee . Vaccines and Related Biological Products Advisory Committee 2024 . Accessed Dec. 13, 2024 . https://www.fda.gov/advisory-committees/blood-vaccines-and-other-biologi...
    1. World Health Organization . Recommendations for Influenza Vaccine Composition 2024 . Accessed Dec. 13, 2024 . https://www.who.int/teams/global-influenza-programme/vaccines/who-recomm...
    1. Hatcher E , Bao Y , Amedeo P , et al. . NCBI will no longer make taxonomy identifiers for individual influenza strains on January 15, 2018 . PeerJ Pre-prints . 2017. ; 5 : e3428v1 . Accessed Apr. 16, 2025 . https://peerj.com/preprints/3428
    1. Burgess T , Richard SA , Collins L , et al. . 2206. Pragmatic assessment of influenza vaccine effectiveness in the Department of Defense (PAIVED): updates from year 4 of a multi-site trial . Open Forum Infect Dis . 2022. ; 9 ( suppl 2 ): ofac492.1825 . doi: 10.1093/ofid/ofac492.1825 - DOI

LinkOut - more resources